Search and Filter
Results per Page:
HVTN Scientific Leadership Development
Meet the 2023 Awardees
National Black HIV/AIDS Awareness Day
Faith to envision a world without HIV
Request for Research Proposals: Imbokodo HIV Vaccine Efficacy Trial (HVTN 705/VAC89220HPX2008)
The HIV Vaccine Trials Network (HVTN), the NIH/NIAID Division of AIDS (DAIDS), and Janssen Vaccines and Prevention are pleased to welcome scientific study proposals involving specimens and/or study data from the Imbokodo (HVTN 705/VAC89220HPX2008) HIV vaccine clinical trial.
Where Are We Now and What’s Next?
Mosaico Study Update
Coordination of COVID-19 Vaccine Clinical Trials Produces a ‘Treasure Trove’ of Data and a Model for the Future
Harmonized approach and vast database of trial participants could bolster future research well beyond SARS-CoV-2
Phase 3 Mosaic-Based Investigational HIV Vaccine Study Discontinued Following Disappointing Results of Planned Data Review
HVTN researchers and ethicists say findings will help guide new approaches to HIV vaccine studies
Faith Forward 2030
Fighting for Our Lives
Communities of Faith Breakfast
Building Partnerships for a One-Community Response to HIV
Dr. Larry Corey receives Alexander Fleming Award
Virologist honored by peers for his lifetime achievements against infectious diseases